Your browser doesn't support javascript.
loading
SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
Wang, Yiding; Pang, Xiaoling; Liu, Yuexin; Mu, Guiling; Wang, Qian.
Afiliación
  • Wang Y; Department of Urology, Liaoning Cancer Hospital and Institute/Cancer Hospital of China Medical University, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning, China.
  • Pang X; Emergency Department, the Fourth Affiliated Hospital of China Medical University, No. 4 Chongshandong Road, Huanggu District, Shenyang 110032, Liaoning, China.
  • Liu Y; Emergency Department, the Fourth Affiliated Hospital of China Medical University, No. 4 Chongshandong Road, Huanggu District, Shenyang 110032, Liaoning, China.
  • Mu G; Central Laboratory, Liaoning Cancer Hospital and Institute/Cancer Hospital of China Medical University, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning, China.
  • Wang Q; Medical Oncology, Department of Gastrointestinal Cancer, Liaoning Cancer Hospital and Institute/Cancer Hospital of China Medical University, No. 44 Xiaoheyan Road, Dadong District, Shenyang 110042, Liaoning, China.
Carcinogenesis ; 44(8-9): 708-715, 2023 12 02.
Article en En | MEDLINE | ID: mdl-37665951

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Ferroptosis Límite: Animals / Humans Idioma: En Revista: Carcinogenesis Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Ferroptosis Límite: Animals / Humans Idioma: En Revista: Carcinogenesis Año: 2023 Tipo del documento: Article País de afiliación: China